Association between lung function decline and obstructive sleep apnoea: the ALEC study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Emilsson, Össur IngiSundbom, Fredrik
Ljunggren, Mirjam
Benediktsdottir, Bryndis
Garcia-Aymerich, Judith
Bui, Dinh Son
Jarvis, Deborah
Olin, Anna-Carin
Franklin, Karl A
Demoly, Pascal
Lindberg, Eva
Janson, Christer
Aspelund, Thor
Gislason, Thorarinn
Issue Date
2020-07-06
Metadata
Show full item recordCitation
Emilsson ÖI, Sundbom F, Ljunggren M, et al. Association between lung function decline and obstructive sleep apnoea: the ALEC study [published online ahead of print, 2020 Jul 6]. Sleep Breath. 2020;10.1007/s11325-020-02086-1. doi:10.1007/s11325-020-02086-1Abstract
Purpose: To study changes in lung function among individuals with a risk of obstructive sleep apnoea (OSA), and if asthma affected this relationship. Methods: We used data from the European Community Respiratory Health Survey II and III, a multicentre general population study. Participants answered questionnaires and performed spirometry at baseline and 10-year follow-up (n = 4,329 attended both visits). Subjects with high risk for OSA were identified from the multivariable apnoea prediction (MAP) index, calculated from BMI, age, gender, and OSA symptoms at follow-up. Asthma was defined as having doctor's diagnosed asthma at follow-up. Primary outcomes were changes in forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) from baseline to follow-up. Results: Among 5108 participants at follow-up, 991 (19%) had a high risk of OSA based on the MAP index. Participants with high OSA risk more often had wheeze, cough, chest tightness, and breathlessness at follow-up than those with low OSA risk. Lung function declined more rapidly in subjects with high OSA risk (low vs high OSA risk [mean ± SD]: FEV1 = - 41.3 ± 24.3 ml/year vs - 50.8 ± 30.1 ml/year; FVC = - 30.5 ± 31.2 ml/year vs - 45.2 ± 36.3 ml/year). Lung function decline was primarily associated with higher BMI and OSA symptoms. OSA symptoms had a stronger association with lung function decline among asthmatics, compared to non-asthmatics. Conclusion: In the general population, a high probability of obstructive sleep apnoea was related to faster lung function decline in the previous decade. This was driven by a higher BMI and more OSA symptoms among these subjects. The association between OSA symptoms and lung function decline was stronger among asthmatics. Keywords: Asthma; Lung function; Lung function decline; Sleep apnoea.Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAdditional Links
https://link.springer.com/article/10.1007/s11325-020-02086-1ae974a485f413a2113503eed53cd6c53
10.1007/s11325-020-02086-1
Scopus Count
Collections
Related articles
- Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.
- Authors: Jonassen TM, Eagan TM, Bjorvatn B, Lehmann S
- Issue date: 2018 Jan
- Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea.
- Authors: Kunos L, Lazar Z, Martinovszky F, Tarnoki AD, Tarnoki DL, Kovacs D, Forgo B, Horvath P, Losonczy G, Bikov A
- Issue date: 2017 Feb
- Obstructive sleep apnoea accelerates FEV<sub>1</sub> decline in asthmatic patients.
- Authors: Wang TY, Lo YL, Lin SM, Huang CD, Chung FT, Lin HC, Wang CH, Kuo HP
- Issue date: 2017 Mar 21
- Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
- Authors: Abramson MJ, Kaushik S, Benke GP, Borg BM, Smith CL, Dharmage SC, Thompson BR
- Issue date: 2016
- Gastro-oesophageal reflux and respiratory symptoms in Busselton adults: the effects of bodyweight and sleep apnoea.
- Authors: Mulrennan SA, Knuiman MW, Divitini ML, Cullen DJ, Hunter M, Hui J, Musk AW, James AL
- Issue date: 2012 Jul